Scarica l'app Stockscreener
193.96
0.10%
0.20
Dopo l'orario di chiusura:
193.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BDX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$193.76
Aprire:
$193.715
Volume 24 ore:
1.78M
Relative Volume:
0.92
Capitalizzazione di mercato:
$55.36B
Reddito:
$21.84B
Utile/perdita netta:
$1.68B
Rapporto P/E:
33.27
EPS:
5.8293
Flusso di cassa netto:
$2.67B
1 W Prestazione:
-0.03%
1M Prestazione:
+9.96%
6M Prestazione:
+13.41%
1 anno Prestazione:
-12.72%
Intervallo 1D:
$193.69
$196.12
Intervallo di 1 settimana:
$189.44
$196.12
Portata 52W:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Nome
Becton Dickinson Co
Settore
Industria
Telefono
(201) 847-6800
Indirizzo
ONE BECTON DR, FRANKLIN LAKES
Confronta BDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
193.96 | 55.30B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
575.34 | 201.58B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
80.73 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
256.55 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
280.23 | 20.27B | 2.96B | 487.70M | 344.00M | 6.6758 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-02 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-05-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Sell → Neutral |
| 2022-07-11 | Downgrade | Citigroup | Neutral → Sell |
| 2022-06-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Ripresa | Raymond James | Mkt Perform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Ripresa | Goldman | Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-07 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-02-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Iniziato | Deutsche Bank | Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-06-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-01-19 | Ripresa | BofA/Merrill | Buy |
| 2018-01-05 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-01-05 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2017-12-29 | Reiterato | Deutsche Bank | Buy |
Mostra tutto
Becton Dickinson Co Borsa (BDX) Ultime notizie
Amundi Increases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson: Pharmaceutical Systems & Core Medical Consumables as Durable Growth Anchors! - Smartkarma
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing - Yahoo Finance
Investors Buy Large Volume of Becton, Dickinson and Company Call Options (NYSE:BDX) - MarketBeat
Vascular Access Devices Market Set for Dynamic Growth with Key Players Becton, Dickinson and Company, Cook - EIN News
Philadelphia Trust Co. Acquires 27,495 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Is Becton Dickinson and Company (BOX) stock a buy for dividend portfoliosWeekly Profit Report & Verified Technical Trade Signals - Newser
Becton Dickinson & Co To Go Ex-Dividend On December 8th, 2025 With 1.05 USD Dividend Per Share - 富途牛牛
Ex-Dividend Reminder: Becton, Dickinson, Nicolet Bankshares and UnitedHealth Group - Nasdaq
BD and ChemoGLO collaborate to expand hazardous drug contamination testing for healthcare facilities and laboratories - marketscreener.com
BD and ChemoGLO Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories - Finviz
Becton, Dickinson & Co. Working With ChemoGLO Partner to Broaden Hazardous Drug Contamination Testing - marketscreener.com
BD and ChemoGLO partner to enhance hazardous drug testing in healthcare By Investing.com - Investing.com South Africa
BD and ChemoGLO partner to enhance hazardous drug testing in healthcare - Investing.com
BD (NYSE: BDX), ChemoGLO partner to speed hazardous drug surface testing to 10 minutes - Stock Titan
Becton, Dickinson and Company (BDX) Stock Forecasts - Yahoo! Finance Canada
1832 Asset Management L.P. Boosts Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
There May Be Reason For Hope In Becton Dickinson's (NYSE:BDX) Disappointing Earnings - Yahoo Finance
Feld Michael, EVP at Becton Dickinson, sells $14502 in stock By Investing.com - Investing.com South Africa
Hundreds of jobs saved at Swindon factory after buyout of US firm - This is Wiltshire
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes - Finviz
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld Michael, EVP at Becton Dickinson, sells $14502 in stock - Investing.com
BECTON DICKINSON EVP Michael Feld Sells 75 Shares - TradingView
VP Feld Sells 75 ($14.5K) Of Becton Dickinson & Co [BDX] - TradingView
BDX: Morgan Stanley Raises Price Target on Becton Dickinson | BD - GuruFocus
Morgan Stanley Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $210 - 富途牛牛
Becton, Dickinson and Company: Target Price Consensus and Analysts Recommendations | BDX | US0758871091 - marketscreener.com
Grantham Mayo Van Otterloo & Co. LLC Invests $965,000 in Becton, Dickinson and Company $BDX - MarketBeat
Is Becton Dickinson and Company stock good for wealth creationMarket Rally & Verified Chart Pattern Signals - Newser
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
VP Shan Acquires 891 Of Becton Dickinson & Co [BDX] - TradingView
VP Neal Acquires 1,071 Of Becton Dickinson & Co [BDX] - TradingView
Europe Glass Prefilled Syringes and Glass Vials Packaging Equipment Market Trends 2035 - GlobeNewswire Inc.
WSA changes HR director – Danish replacement found in the US - medwatch.com
Is Becton, Dickinson and Company Stock Underperforming the Nasdaq? - Yahoo Finance
Does Europe’s First CE-Approved Surgical Irrigation System Shift the Bull Case for BD (BDX)? - simplywall.st
Becton Dickinson (BDX): Evaluating Valuation After European Launch of Surgiphor and Recent Strategic Moves - simplywall.st
Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 66% Above Its Share Price - Yahoo Finance
Becton Dickinson Faces Risks in Biosciences and Diagnostic Merger with Waters - The Globe and Mail
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt? - 富途牛牛
Becton Dickinson (BDX) Margin Decline Reinforces Bearish Revenue Growth Narrative in FY2025 - simplywall.st
BECTON DICKINSON & CO SEC 10-K Report - TradingView
Here's Why Becton Dickinson (BDX) is a Strong Value Stock - Yahoo Finance
Becton Dickinson (NYSE:BDX) Has Announced That It Will Be Increasing Its Dividend To $1.05 - Yahoo Finance
Waters Proposed Acquisition of Becton, Dickinson's Biosciences, Diagnostic Operations Gets EC's Approval - 富途牛牛
How Does Becton Dickinson Stack Up After Regulatory News and Recent Price Swings? - Yahoo Finance UK
Becton Dickinson & Co. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Will Becton Dickinson and Company stock sustain bullish trend into 20252025 Price Action Summary & Fast Entry Momentum Alerts - newser.com
Will Becton Dickinson and Company stock see PE expansion2025 Key Lessons & Safe Investment Capital Preservation Plans - newser.com
Becton Dickinson Co Azioni (BDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.20%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):